Evidence map›Paper›PMID 40034339›Full record

ArticleBiofilm2025

Early fibrin biofilm development in cardiovascular infections.

Safae Oukrich, Jane Hong, Mariël Leon-Grooters, Wiggert A van Cappellen, Johan A Slotman, Gijsje H Koenderink, Willem J B van Wamel, Moniek P M de Maat, Klazina Kooiman, Kirby R Lattwein

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biofilm, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. What Is a Biofilm? Lessons Learned from Interactions with Immune Cells.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Safae OukrichBiomedical Engineering, Department of Cardiology, Cardiovascular Institute, Erasmus MC, P.O. Box 2040, 3000 CA, Rotterdam, the Netherlands.
Jane HongBiomedical Engineering, Department of Cardiology, Cardiovascular Institute, Erasmus MC, P.O. Box 2040, 3000 CA, Rotterdam, the Netherlands.
Mariël Leon-GrootersBiomedical Engineering, Department of Cardiology, Cardiovascular Institute, Erasmus MC, P.O. Box 2040, 3000 CA, Rotterdam, the Netherlands.
Wiggert A van CappellenErasmus Optical Imaging Center, Erasmus MC, P.O. Box 2040, 3000 CA, Rotterdam, the Netherlands.
Johan A SlotmanErasmus Optical Imaging Center, Erasmus MC, P.O. Box 2040, 3000 CA, Rotterdam, the Netherlands.
Gijsje H KoenderinkDepartment of Bionanoscience, Kavli Institute of Nanoscience, Delft University of Technology, P.O Box 5046, 2600 GA, Delft, the Netherlands.
Willem J B van WamelDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC, P.O. Box 2040, 3000 CA, Rotterdam, the Netherlands.
Moniek P M de MaatDepartment of Hematology, Cardiovascular Institute, Erasmus MC, P.O. Box 2040, 3000 CA, Rotterdam, the Netherlands.
Klazina KooimanBiomedical Engineering, Department of Cardiology, Cardiovascular Institute, Erasmus MC, P.O. Box 2040, 3000 CA, Rotterdam, the Netherlands.
Kirby R LattweinBiomedical Engineering, Department of Cardiology, Cardiovascular Institute, Erasmus MC, P.O. Box 2040, 3000 CA, Rotterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The single most common microbe causing cardiovascular infections is

Indexed as

Biofilm developmentCardiovascular infectionsCoagulaseFibrinFibrinogenStaphylococcus aureus

Identifiers

PMID40034339
PMCPMC11872660

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.